Status:
COMPLETED
AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction
Lead Sponsor:
Aggredyne, Inc.
Conditions:
Platelet Dysfunction Due to Aspirin Ingestion
Eligibility:
All Genders
18+ years
Brief Summary
To test the AggreGuide A-100 AA Assay's effectiveness for detecting aspirin induced platelet dysfunction.
Eligibility Criteria
Inclusion
- over 18
Exclusion
- on aspirin in prior week
- medical history of platelet disorders
- contraindications to aspirin
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01915407
Start Date
April 1 2013
End Date
July 1 2013
Last Update
August 2 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aggredyne, Inc.
Houston, Texas, United States, 77099